<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(1)</volume><submitter>Lv Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Recent studies have highlighted the role of miR-5195-3p in suppressing cell growth in various cancers. However, the specific functional impact of miR-5195-3p in colorectal cancer (CRC) remain to be fully clarified. The importance of miR-5195-3p in CRC was evaluated, aiming to uncover its underlying molecular mechanism and identify it as a potential therapeutic target for CRC.&lt;h4>Results&lt;/h4>Our research has shown that miR-5195-3p is markedly under-expressed in CRC tissues and cell cultures, with its reduced presence associated with a higher TNM stage, lymphatic invasion, and unfavorable survival outcome. Ectopic miR-5195-3p expression curtailed proliferation, migration, and invasion of SW1116 and HT29 cells. Additionally, we discovered that miR-5195-3p directly targets a</pubmed_abstract><journal>Cell division</journal><pagination>29</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11468180</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MiR-5195-3p predicts clinical prognosis and represses colorectal cancer progression by targeting TLR4/MyD88 signaling.</pubmed_title><pmcid>PMC11468180</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Lu Y</pubmed_authors><pubmed_authors>Lv Y</pubmed_authors><pubmed_authors>Guo S</pubmed_authors><pubmed_authors>Wang K</pubmed_authors><pubmed_authors>Jin L</pubmed_authors></additional><is_claimable>false</is_claimable><name>MiR-5195-3p predicts clinical prognosis and represses colorectal cancer progression by targeting TLR4/MyD88 signaling.</name><description>&lt;h4>Background&lt;/h4>Recent studies have highlighted the role of miR-5195-3p in suppressing cell growth in various cancers. However, the specific functional impact of miR-5195-3p in colorectal cancer (CRC) remain to be fully clarified. The importance of miR-5195-3p in CRC was evaluated, aiming to uncover its underlying molecular mechanism and identify it as a potential therapeutic target for CRC.&lt;h4>Results&lt;/h4>Our research has shown that miR-5195-3p is markedly under-expressed in CRC tissues and cell cultures, with its reduced presence associated with a higher TNM stage, lymphatic invasion, and unfavorable survival outcome. Ectopic miR-5195-3p expression curtailed proliferation, migration, and invasion of SW1116 and HT29 cells. Additionally, we discovered that miR-5195-3p directly targets a</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2025-04-04T13:54:48.029Z</modification><creation>2025-04-04T13:54:48.029Z</creation></dates><accession>S-EPMC11468180</accession><cross_references><pubmed>39390599</pubmed><doi>10.1186/s13008-024-00133-x</doi></cross_references></HashMap>